Eli Lilly (LLY) return on equity (ROE)

Return on equity · fiscal 2025
77.8%

Eli Lilly (LLY) earned a return on equity of 77.8% in fiscal 2025 (the year ended December 31, 2025). That is 3.6 percentage points higher than the 74.2% of fiscal 2024. Figures as of 17 Nov 2026, 19:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
77.8%
Change on fiscal 2024
+3.6 pts
Highest on record
319.1%fiscal 2019
Lowest on record
-30.8%fiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Eli Lilly return on equity (ROE), in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 319.1% in fiscal 2019 and the lowest -30.8% in fiscal 2008. The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is 32.9%.

History · 18 fiscal years

Return on equity by fiscal year

Eli Lilly return on equity (ROE), year by year

Eli Lilly (LLY) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202577.8% 3.6 pts up
202474.2% 25.6 pts up
202348.6% 10.0 pts down
202258.6% 3.5 pts down
202162.2% 47.6 pts down
2020109.8% 209.3 pts down
2019319.1% 286.2 pts up
201832.9% 34.6 pts up
2017-1.8% 21.3 pts down
201619.5% 3.0 pts up
201516.5% 1.0 pts up
201415.5% 11.0 pts down
201326.6% 1.1 pts down
201227.7% 4.4 pts down
201132.1% 8.7 pts down
201040.8% 4.6 pts down
200945.4% 76.2 pts up
2008-30.8%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on LLY

Eli Lilly, figure by figure

Eli Lilly (LLY) overview: price, valuation and scorecardAll health care companies by market value

Eli Lilly return on equity (ROE): questions and answers

What is Eli Lilly's return on equity?

Eli Lilly (LLY) earned a return on equity of 77.8% in fiscal 2025 (the year ended December 31, 2025). That is 3.6 percentage points higher than the 74.2% of fiscal 2024.

Is Eli Lilly's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is 32.9%.

What are the highest and lowest return on equity figures on record for Eli Lilly?

Across the 18 fiscal years on record (2008–2025), the highest was 319.1% in fiscal 2019 and the lowest -30.8% in fiscal 2008.

How is Eli Lilly's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Eli Lilly (LLY) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.